Logo image of CYR.DE

CYAN AG (CYR.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:CYR - DE000A2E4SV8 - Common Stock

2.22 EUR
-0.02 (-0.89%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYR. CYR was compared to 116 industry peers in the Software industry. The financial health of CYR is average, but there are quite some concerns on its profitability. CYR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

CYR had negative earnings in the past year.
CYR had a negative operating cash flow in the past year.
In the past 5 years CYR always reported negative net income.
In the past 5 years CYR always reported negative operating cash flow.
CYR.DE Yearly Net Income VS EBIT VS OCF VS FCFCYR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M -15M -20M

1.2 Ratios

CYR's Return On Assets of -6.26% is on the low side compared to the rest of the industry. CYR is outperformed by 74.14% of its industry peers.
The Return On Equity of CYR (-7.08%) is worse than 63.79% of its industry peers.
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROIC N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
CYR.DE Yearly ROA, ROE, ROICCYR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

With an excellent Gross Margin value of 84.83%, CYR belongs to the best of the industry, outperforming 80.17% of the companies in the same industry.
In the last couple of years the Gross Margin of CYR has declined.
The Profit Margin and Operating Margin are not available for CYR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 84.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
CYR.DE Yearly Profit, Operating, Gross MarginsCYR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

6

2. Health

2.1 Basic Checks

CYR does not have a ROIC to compare to the WACC, probably because it is not profitable.
CYR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CYR has more shares outstanding
Compared to 1 year ago, CYR has a worse debt to assets ratio.
CYR.DE Yearly Shares OutstandingCYR.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CYR.DE Yearly Total Debt VS Total AssetsCYR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

CYR has an Altman-Z score of 5.54. This indicates that CYR is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CYR (5.54) is better than 73.28% of its industry peers.
CYR has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.05, CYR belongs to the best of the industry, outperforming 81.03% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 5.54
ROIC/WACCN/A
WACC7.52%
CYR.DE Yearly LT Debt VS Equity VS FCFCYR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.24 indicates that CYR has no problem at all paying its short term obligations.
CYR has a Current ratio of 2.24. This is amongst the best in the industry. CYR outperforms 80.17% of its industry peers.
CYR has a Quick Ratio of 2.24. This indicates that CYR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CYR (2.24) is better than 81.03% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
CYR.DE Yearly Current Assets VS Current LiabilitesCYR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

5

3. Growth

3.1 Past

CYR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.12%, which is quite impressive.
The Revenue has grown by 98.99% in the past year. This is a very strong growth!
Measured over the past years, CYR shows a very negative growth in Revenue. The Revenue has been decreasing by -23.31% on average per year.
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%

3.2 Future

CYR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.17% yearly.
Based on estimates for the next years, CYR will show a very strong growth in Revenue. The Revenue will grow by 22.03% on average per year.
EPS Next Y78.57%
EPS Next 2Y42.5%
EPS Next 3Y17.9%
EPS Next 5Y34.17%
Revenue Next Year31.65%
Revenue Next 2Y27.23%
Revenue Next 3Y38.85%
Revenue Next 5Y22.03%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CYR.DE Yearly Revenue VS EstimatesCYR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M
CYR.DE Yearly EPS VS EstimatesCYR.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

0

4. Valuation

4.1 Price/Earnings Ratio

CYR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 439.60, which means the current valuation is very expensive for CYR.
Based on the Price/Forward Earnings ratio, CYR is valued a bit more expensive than the industry average as 70.69% of the companies are valued more cheaply.
Compared to an average S&P500 Price/Forward Earnings ratio of 36.21, CYR is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 439.6
CYR.DE Price Earnings VS Forward Price EarningsCYR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400

4.2 Price Multiples

68.97% of the companies in the same industry are cheaper than CYR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 124.21
CYR.DE Per share dataCYR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8 1

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as CYR's earnings are expected to grow with 17.90% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.5%
EPS Next 3Y17.9%

0

5. Dividend

5.1 Amount

No dividends for CYR!.
Industry RankSector Rank
Dividend Yield N/A

CYAN AG

FRA:CYR (11/28/2025, 7:00:00 PM)

2.22

-0.02 (-0.89%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-25 2025-09-25
Earnings (Next)05-13 2026-05-13/amc
Inst Owners1.59%
Inst Owner ChangeN/A
Ins Owners38.4%
Ins Owner ChangeN/A
Market Cap48.13M
Revenue(TTM)8.28M
Net Income(TTM)-1.96M
Analysts83.33
Price Target4.44 (100%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19.51%
PT rev (3m)25.84%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)41.67%
EPS NY rev (3m)41.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 439.6
P/S 5.81
P/FCF N/A
P/OCF N/A
P/B 1.74
P/tB 21.86
EV/EBITDA 124.21
EPS(TTM)-0.1
EYN/A
EPS(NY)0.01
Fwd EY0.23%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0.38
BVpS1.28
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.26%
ROE -7.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 84.83%
FCFM N/A
ROA(3y)-27.68%
ROA(5y)-21.43%
ROE(3y)-36.79%
ROE(5y)-28.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y44.24%
GM growth 5Y-3.74%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA 3.19
Cap/Depr 1.57%
Cap/Sales 0.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 5.54
F-Score5
WACC7.52%
ROIC/WACCN/A
Cap/Depr(3y)16.18%
Cap/Depr(5y)14.33%
Cap/Sales(3y)12.45%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80%
EPS Next Y78.57%
EPS Next 2Y42.5%
EPS Next 3Y17.9%
EPS Next 5Y34.17%
Revenue 1Y (TTM)98.99%
Revenue growth 3Y-5.78%
Revenue growth 5Y-23.31%
Sales Q2Q%36.96%
Revenue Next Year31.65%
Revenue Next 2Y27.23%
Revenue Next 3Y38.85%
Revenue Next 5Y22.03%
EBIT growth 1Y-16.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.87%
EBIT Next 3Y55.63%
EBIT Next 5Y31.67%
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.64%
OCF growth 3YN/A
OCF growth 5YN/A

CYAN AG / CYR.DE FAQ

What is the ChartMill fundamental rating of CYAN AG (CYR.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CYR.DE.


Can you provide the valuation status for CYAN AG?

ChartMill assigns a valuation rating of 0 / 10 to CYAN AG (CYR.DE). This can be considered as Overvalued.


What is the profitability of CYR stock?

CYAN AG (CYR.DE) has a profitability rating of 1 / 10.


What is the expected EPS growth for CYAN AG (CYR.DE) stock?

The Earnings per Share (EPS) of CYAN AG (CYR.DE) is expected to grow by 78.57% in the next year.